IT8520234A0 - Composizione farmaceutiche adattivita' dopominergica. - Google Patents

Composizione farmaceutiche adattivita' dopominergica.

Info

Publication number
IT8520234A0
IT8520234A0 IT8520234A IT2023485A IT8520234A0 IT 8520234 A0 IT8520234 A0 IT 8520234A0 IT 8520234 A IT8520234 A IT 8520234A IT 2023485 A IT2023485 A IT 2023485A IT 8520234 A0 IT8520234 A0 IT 8520234A0
Authority
IT
Italy
Prior art keywords
postminergic
adaptivity
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
IT8520234A
Other languages
English (en)
Other versions
IT1200603B (it
Inventor
Stefano Poli
Original Assignee
Poli Ind Chimica Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Poli Ind Chimica Spa filed Critical Poli Ind Chimica Spa
Priority to IT20234/85A priority Critical patent/IT1200603B/it
Publication of IT8520234A0 publication Critical patent/IT8520234A0/it
Priority to DE19853525390 priority patent/DE3525390A1/de
Priority to GB8607848A priority patent/GB2173101B/en
Priority to US06/847,395 priority patent/US4673681A/en
Priority to JP61077528A priority patent/JPS61257922A/ja
Priority to FR868604772A priority patent/FR2579893B1/fr
Application granted granted Critical
Publication of IT1200603B publication Critical patent/IT1200603B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
IT20234/85A 1985-04-04 1985-04-04 Composizione farmaceutiche ad attivita dopaminergica IT1200603B (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
IT20234/85A IT1200603B (it) 1985-04-04 1985-04-04 Composizione farmaceutiche ad attivita dopaminergica
DE19853525390 DE3525390A1 (de) 1985-04-04 1985-07-16 Verwendung von (alpha)-dihydroergokryptin zur behandlung des parkinson-syndroms, von depressionen und zephalalgien
GB8607848A GB2173101B (en) 1985-04-04 1986-03-27 Dopaminergic compositions containing dihydroergocryptine
US06/847,395 US4673681A (en) 1985-04-04 1986-04-02 Pharmaceutical methods having dopaminergic activity
JP61077528A JPS61257922A (ja) 1985-04-04 1986-04-03 医薬組成物
FR868604772A FR2579893B1 (it) 1985-04-04 1986-04-03

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT20234/85A IT1200603B (it) 1985-04-04 1985-04-04 Composizione farmaceutiche ad attivita dopaminergica

Publications (2)

Publication Number Publication Date
IT8520234A0 true IT8520234A0 (it) 1985-04-04
IT1200603B IT1200603B (it) 1989-01-27

Family

ID=11164998

Family Applications (1)

Application Number Title Priority Date Filing Date
IT20234/85A IT1200603B (it) 1985-04-04 1985-04-04 Composizione farmaceutiche ad attivita dopaminergica

Country Status (6)

Country Link
US (1) US4673681A (it)
JP (1) JPS61257922A (it)
DE (1) DE3525390A1 (it)
FR (1) FR2579893B1 (it)
GB (1) GB2173101B (it)
IT (1) IT1200603B (it)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1245369B (it) * 1991-03-28 1994-09-20 Poli Ind Chimica Spa Medicamento contenente alfa-diidroergocriptina ad azione neuroprotettrice
IT1252163B (it) * 1991-12-03 1995-06-05 Poli Ind Chimica Spa Composizioni farmaceutiche per la neuroprotezione nelle malattie neurologiche di carattere degenerativo o su base ischemica
DE10043321B4 (de) * 2000-08-24 2005-07-28 Neurobiotec Gmbh Verwendung eines transdermalen therapeutischen Systems zur Behandlung der Parkinsonschen Krankheit, zur Behandlung und Prävention des prämenstruellen Syndroms und zur Lactationshemmung
DE10053397A1 (de) * 2000-10-20 2002-05-02 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
US20070243240A9 (en) * 2000-08-24 2007-10-18 Fred Windt-Hanke Transdermal therapeutic system
DE10064453A1 (de) * 2000-12-16 2002-07-04 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
ITMI20041855A1 (it) * 2004-09-29 2004-12-29 Polichem Sa Composizioni farmaceutiche di alfa-diidroergocriptina per uso transdermico e-o transmucoso.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1202885A (en) * 1966-12-22 1970-08-19 Sandoz Ltd Pharmaceutical compositions comprising alkaloids
NL7314066A (it) * 1972-10-18 1974-04-22
DE3043210A1 (de) * 1979-11-27 1981-08-27 Sandoz-Patent-GmbH, 7850 Lörrach Ergolinderivate, verfahren zu deren herstellung, diese enthaltende pharmazeutische zusammensetzungen und ihre anwendung bei der therapeutischen behandlung

Also Published As

Publication number Publication date
GB2173101A (en) 1986-10-08
JPS61257922A (ja) 1986-11-15
GB8607848D0 (en) 1986-04-30
JPH0415767B2 (it) 1992-03-19
US4673681A (en) 1987-06-16
FR2579893B1 (it) 1991-07-05
IT1200603B (it) 1989-01-27
GB2173101B (en) 1989-09-20
DE3525390A1 (de) 1986-10-09
FR2579893A1 (it) 1986-10-10
DE3525390C2 (it) 1988-07-28

Similar Documents

Publication Publication Date Title
IT8522800A0 (it) Composizione effeverscente adattivita' analgesica.
IT8621358A0 (it) Composizione farmaceutica adattivita' analgesica.
SE8801813L (sv) Pharmaceutical composition
FI862094A (fi) Bornerande terapeutisk komposition.
KR890701101A (ko) 제약학적 조성물
FR2583763B1 (fr) Composition d'essence
IT8323205A0 (it) Composizioni farmaceutiche adattivita' antiinfiammatoria e/o analgesica, non ulcerogene.
DE3682083D1 (de) Pharmazeutische zusammensetzungen.
DE3669105D1 (de) Therapeutische zusammensetzung.
IT8521498A0 (it) Isoindolinil-alchil-piperazine adattivita' farmaceutica.
IT1213453B (it) Composizione farmaceutica.
DE3674040D1 (de) Pharmazeutische zusammensetzungen.
IT1209615B (it) Composizione farmaceutica
IT8319958A0 (it) Composizioni farmaceutiche adattivita' antineoplastica.
IT8520234A0 (it) Composizione farmaceutiche adattivita' dopominergica.
IT8619162A0 (it) Composti acilamminoalcanoilici adattivita' farmaceutica.
DE3669656D1 (de) Azanaphthalene enthaltende arzneimittelzusammensetzungen.
IT8322427A0 (it) Composizioni farmaceutiche adattivita'antibiotica-immunostimolante.
IT8520273A0 (it) Composizioni farmaceutiche adattivita' antigalattopoietica.
IT8520591A0 (it) Formulazione farmaceutica.
IT1203737B (it) Composizioni farmaceutiche comprendenti 3-amminopropossi-indoli
FR2583416B1 (fr) Composition d'aminobenzylamines.
DE3667915D1 (de) Pharmazeutische zusammensetzung.
IT8220251A0 (it) Composizione farmaceutica adattivita' immunomodulatrice.
IT8621925A0 (it) Composizioni farmaceutiche adattivita' antineoplastica.

Legal Events

Date Code Title Description
ITCP Complementary protection certificate

Free format text: CCP 3

MEDD Supplementary protection certificate for pharmaceutical products: granted

Free format text: CCP 3, 19911211; POLI INDUSTRIA CHIMICA S.P.A.(1)

TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970329